nodes	percent_of_prediction	percent_of_DWPC	metapath
Apraclonidine—Rhinorrhoea—Telbivudine—hepatitis B	0.0342	0.0342	CcSEcCtD
Apraclonidine—Rhinorrhoea—Lamivudine—hepatitis B	0.0193	0.0193	CcSEcCtD
Apraclonidine—Nasopharyngitis—Telbivudine—hepatitis B	0.018	0.018	CcSEcCtD
Apraclonidine—Vasodilation procedure—Lamivudine—hepatitis B	0.0178	0.0178	CcSEcCtD
Apraclonidine—Vasodilation—Lamivudine—hepatitis B	0.0178	0.0178	CcSEcCtD
Apraclonidine—Oedema peripheral—Entecavir—hepatitis B	0.0167	0.0167	CcSEcCtD
Apraclonidine—Abdominal discomfort—Telbivudine—hepatitis B	0.0167	0.0167	CcSEcCtD
Apraclonidine—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.0164	0.0164	CcSEcCtD
Apraclonidine—Inflammation—Lamivudine—hepatitis B	0.0161	0.0161	CcSEcCtD
Apraclonidine—Mental disorder—Entecavir—hepatitis B	0.0149	0.0149	CcSEcCtD
Apraclonidine—Photophobia—Lamivudine—hepatitis B	0.0147	0.0147	CcSEcCtD
Apraclonidine—Pharyngitis—Telbivudine—hepatitis B	0.0138	0.0138	CcSEcCtD
Apraclonidine—Mediastinal disorder—Telbivudine—hepatitis B	0.0126	0.0126	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.0125	0.0125	CcSEcCtD
Apraclonidine—Myalgia—Adefovir Dipivoxil—hepatitis B	0.0123	0.0123	CcSEcCtD
Apraclonidine—Chest pain—Adefovir Dipivoxil—hepatitis B	0.0123	0.0123	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.0122	0.0122	CcSEcCtD
Apraclonidine—Infection—Entecavir—hepatitis B	0.012	0.012	CcSEcCtD
Apraclonidine—Dysgeusia—Telbivudine—hepatitis B	0.0119	0.0119	CcSEcCtD
Apraclonidine—Nervous system disorder—Entecavir—hepatitis B	0.0118	0.0118	CcSEcCtD
Apraclonidine—Skin disorder—Entecavir—hepatitis B	0.0117	0.0117	CcSEcCtD
Apraclonidine—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.0115	0.0115	CcSEcCtD
Apraclonidine—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.0114	0.0114	CcSEcCtD
Apraclonidine—Ill-defined disorder—Telbivudine—hepatitis B	0.0113	0.0113	CcSEcCtD
Apraclonidine—Malaise—Telbivudine—hepatitis B	0.0109	0.0109	CcSEcCtD
Apraclonidine—Insomnia—Entecavir—hepatitis B	0.0109	0.0109	CcSEcCtD
Apraclonidine—Somnolence—Entecavir—hepatitis B	0.0107	0.0107	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.0107	0.0107	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Entecavir—hepatitis B	0.0104	0.0104	CcSEcCtD
Apraclonidine—Fatigue—Entecavir—hepatitis B	0.0104	0.0104	CcSEcCtD
Apraclonidine—Chest pain—Telbivudine—hepatitis B	0.0103	0.0103	CcSEcCtD
Apraclonidine—Myalgia—Telbivudine—hepatitis B	0.0103	0.0103	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.0103	0.0103	CcSEcCtD
Apraclonidine—Discomfort—Telbivudine—hepatitis B	0.0102	0.0102	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.0102	0.0102	CcSEcCtD
Apraclonidine—Nasopharyngitis—Lamivudine—hepatitis B	0.0101	0.0101	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Entecavir—hepatitis B	0.00985	0.00985	CcSEcCtD
Apraclonidine—Nervous system disorder—Telbivudine—hepatitis B	0.00971	0.00971	CcSEcCtD
Apraclonidine—Skin disorder—Telbivudine—hepatitis B	0.00962	0.00962	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00961	0.00961	CcSEcCtD
Apraclonidine—Abdominal pain—Entecavir—hepatitis B	0.00953	0.00953	CcSEcCtD
Apraclonidine—Abdominal discomfort—Lamivudine—hepatitis B	0.0094	0.0094	CcSEcCtD
Apraclonidine—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00929	0.00929	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00902	0.00902	CcSEcCtD
Apraclonidine—Insomnia—Telbivudine—hepatitis B	0.00895	0.00895	CcSEcCtD
Apraclonidine—Paraesthesia—Telbivudine—hepatitis B	0.00889	0.00889	CcSEcCtD
Apraclonidine—Asthenia—Entecavir—hepatitis B	0.00865	0.00865	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00855	0.00855	CcSEcCtD
Apraclonidine—Fatigue—Telbivudine—hepatitis B	0.00853	0.00853	CcSEcCtD
Apraclonidine—Pain—Telbivudine—hepatitis B	0.00847	0.00847	CcSEcCtD
Apraclonidine—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00844	0.00844	CcSEcCtD
Apraclonidine—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00832	0.00832	CcSEcCtD
Apraclonidine—Diarrhoea—Entecavir—hepatitis B	0.00824	0.00824	CcSEcCtD
Apraclonidine—Feeling abnormal—Telbivudine—hepatitis B	0.00816	0.00816	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Telbivudine—hepatitis B	0.00809	0.00809	CcSEcCtD
Apraclonidine—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00804	0.00804	CcSEcCtD
Apraclonidine—Dizziness—Entecavir—hepatitis B	0.00797	0.00797	CcSEcCtD
Apraclonidine—Rhinitis—Lamivudine—hepatitis B	0.00787	0.00787	CcSEcCtD
Apraclonidine—Abdominal pain—Telbivudine—hepatitis B	0.00783	0.00783	CcSEcCtD
Apraclonidine—Pharyngitis—Lamivudine—hepatitis B	0.00779	0.00779	CcSEcCtD
Apraclonidine—Vomiting—Entecavir—hepatitis B	0.00766	0.00766	CcSEcCtD
Apraclonidine—Dermatitis—Entecavir—hepatitis B	0.00759	0.00759	CcSEcCtD
Apraclonidine—Headache—Entecavir—hepatitis B	0.00755	0.00755	CcSEcCtD
Apraclonidine—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00748	0.00748	CcSEcCtD
Apraclonidine—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00741	0.00741	CcSEcCtD
Apraclonidine—Headache—Adefovir Dipivoxil—hepatitis B	0.00737	0.00737	CcSEcCtD
Apraclonidine—Nausea—Entecavir—hepatitis B	0.00716	0.00716	CcSEcCtD
Apraclonidine—Asthenia—Telbivudine—hepatitis B	0.0071	0.0071	CcSEcCtD
Apraclonidine—Mediastinal disorder—Lamivudine—hepatitis B	0.00708	0.00708	CcSEcCtD
Apraclonidine—Pruritus—Telbivudine—hepatitis B	0.007	0.007	CcSEcCtD
Apraclonidine—Nausea—Adefovir Dipivoxil—hepatitis B	0.00698	0.00698	CcSEcCtD
Apraclonidine—Erythema—Lamivudine—hepatitis B	0.00684	0.00684	CcSEcCtD
Apraclonidine—Diarrhoea—Telbivudine—hepatitis B	0.00677	0.00677	CcSEcCtD
Apraclonidine—Tension—Lamivudine—hepatitis B	0.00671	0.00671	CcSEcCtD
Apraclonidine—Dysgeusia—Lamivudine—hepatitis B	0.00669	0.00669	CcSEcCtD
Apraclonidine—Nervousness—Lamivudine—hepatitis B	0.00664	0.00664	CcSEcCtD
Apraclonidine—Dizziness—Telbivudine—hepatitis B	0.00655	0.00655	CcSEcCtD
Apraclonidine—Ill-defined disorder—Lamivudine—hepatitis B	0.00634	0.00634	CcSEcCtD
Apraclonidine—Vomiting—Telbivudine—hepatitis B	0.00629	0.00629	CcSEcCtD
Apraclonidine—Dermatitis—Telbivudine—hepatitis B	0.00624	0.00624	CcSEcCtD
Apraclonidine—Headache—Telbivudine—hepatitis B	0.0062	0.0062	CcSEcCtD
Apraclonidine—Malaise—Lamivudine—hepatitis B	0.00616	0.00616	CcSEcCtD
Apraclonidine—Syncope—Lamivudine—hepatitis B	0.00613	0.00613	CcSEcCtD
Apraclonidine—Nausea—Telbivudine—hepatitis B	0.00588	0.00588	CcSEcCtD
Apraclonidine—Myalgia—Lamivudine—hepatitis B	0.00582	0.00582	CcSEcCtD
Apraclonidine—Chest pain—Lamivudine—hepatitis B	0.00582	0.00582	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00578	0.00578	CcSEcCtD
Apraclonidine—Discomfort—Lamivudine—hepatitis B	0.00575	0.00575	CcSEcCtD
Apraclonidine—Dry mouth—Lamivudine—hepatitis B	0.00569	0.00569	CcSEcCtD
Apraclonidine—Oedema—Lamivudine—hepatitis B	0.00558	0.00558	CcSEcCtD
Apraclonidine—Infection—Lamivudine—hepatitis B	0.00554	0.00554	CcSEcCtD
Apraclonidine—Nervous system disorder—Lamivudine—hepatitis B	0.00547	0.00547	CcSEcCtD
Apraclonidine—Skin disorder—Lamivudine—hepatitis B	0.00542	0.00542	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00508	0.00508	CcSEcCtD
Apraclonidine—Insomnia—Lamivudine—hepatitis B	0.00505	0.00505	CcSEcCtD
Apraclonidine—Paraesthesia—Lamivudine—hepatitis B	0.00501	0.00501	CcSEcCtD
Apraclonidine—Dyspnoea—Lamivudine—hepatitis B	0.00497	0.00497	CcSEcCtD
Apraclonidine—Somnolence—Lamivudine—hepatitis B	0.00496	0.00496	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00482	0.00482	CcSEcCtD
Apraclonidine—Fatigue—Lamivudine—hepatitis B	0.00481	0.00481	CcSEcCtD
Apraclonidine—Constipation—Lamivudine—hepatitis B	0.00477	0.00477	CcSEcCtD
Apraclonidine—Pain—Lamivudine—hepatitis B	0.00477	0.00477	CcSEcCtD
Apraclonidine—Feeling abnormal—Lamivudine—hepatitis B	0.0046	0.0046	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Lamivudine—hepatitis B	0.00456	0.00456	CcSEcCtD
Apraclonidine—Abdominal pain—Lamivudine—hepatitis B	0.00441	0.00441	CcSEcCtD
Apraclonidine—Hypersensitivity—Lamivudine—hepatitis B	0.00411	0.00411	CcSEcCtD
Apraclonidine—Asthenia—Lamivudine—hepatitis B	0.004	0.004	CcSEcCtD
Apraclonidine—Pruritus—Lamivudine—hepatitis B	0.00395	0.00395	CcSEcCtD
Apraclonidine—Diarrhoea—Lamivudine—hepatitis B	0.00382	0.00382	CcSEcCtD
Apraclonidine—Dizziness—Lamivudine—hepatitis B	0.00369	0.00369	CcSEcCtD
Apraclonidine—Vomiting—Lamivudine—hepatitis B	0.00355	0.00355	CcSEcCtD
Apraclonidine—Dermatitis—Lamivudine—hepatitis B	0.00351	0.00351	CcSEcCtD
Apraclonidine—Headache—Lamivudine—hepatitis B	0.00349	0.00349	CcSEcCtD
Apraclonidine—Nausea—Lamivudine—hepatitis B	0.00331	0.00331	CcSEcCtD
